Isolagen pivotal study
This article was originally published in The Gray Sheet
Executive Summary
Initial stage of 158-patient Phase III trial for autologous cellular skin therapy is completed. The technology, which the firm plans to launch in 2005, cultures a skin biopsy from behind the ear and implants newly grown fibroblasts in order to regenerate collagen (1"The Gray Sheet" Feb. 16, 2004, p. 16). Early study results show 77% efficacy at four months. Isolagen expects efficacy to improve over six months of follow-up...